Contact

Paxman publishes newsletter on the world’s first Scalp Cooling Summit in May

Today, Paxman publishes the March issue of its newsletter aimed at shareholders, investors and other interested parties.

This month’s issue highlights that Paxman will be hosting the first ever Scalp Cooling Summit, where innovative leaders in the industry come together to talk all things scalp cooling, on 5 May 2022. This international, digitally hosted event will include a series of talks, keynote discussions and live dialogue, where world experts will share the challenges they face in side effect management, alongside their experiences and the solutions they have developed. Institutions represented in the speaker list include Memorial Sloan Kettering Cancer Center, New York, USA; Tata Memorial Hospital, Mumbai, India; Dana Farber Cancer Institute, Boston, USA; Seattle Cancer Care Alliance, Washington, USA; Kyoto University, Japan.

The newsletter also includes information on Paxman’s continued partnership with the US non-profit organisation Living Beyond Breast Cancer, the second episode of the Changing the Face of Cancer podcast with a focus on hair regrowth, as well as multiple US orders for five states, UK orders for existing customers and international orders to Belgium, France, Italy, the Netherlands, Sweden and Japan.

To read the newsletter and subscribe for upcoming issues, follow this link:

https://bit.ly/paxmar22en

Paxman’s investor newsletter is published monthly as a part of the company’s effort to strengthen its market communication together with the IR communication agency Honeybadger. Every published issue of the newsletter is available on Paxman’s website for investors, www.paxman.se. The company encourages feedback and requests on topics for upcoming issues of the newsletter.

What we do
Paxman are world leaders in chemotherapy side effect management on an ambitious journey to change the face of cancer through cryotherapy-based treatments. The Paxman mission is to democratise access to scalp cooling globally.
Learn more →
Financial Information
Read the latest Paxman financial reports. In these comprehensive documents, you will find a detailed overview of our financial performance, key milestones, and a strategic outlook for the future. Reports are published quarterly and annually.
Read reports  →
Investing in Paxman
Paxman has treated 100,000+ patients and installed 5,000+ systems in more than 65 countries worldwide. We are helping to manage the trauma of chemotherapy hair loss. By investing in Paxman, you're not just supporting a company; you're joining us in changing the face of cancer.
Visit the Investor Centre →
linkedin facebook pinterest youtube rss twitter instagram facebook-blank rss-blank linkedin-blank pinterest youtube twitter instagram